UPDATE 1-Puma Biotech says cancer drug fails mid-stage study
November 13, 2014 at 17:29 PM EST
Nov 13 (Reuters) - Puma Biotechnology Inc said its cancer drug failed as a primary treatment for breast cancer patients in a mid-stage study, sending its shares down 14 percent in extended trading.
